Midatech Pharma Plc Propriété du management
Quel est le Propriété du management de Midatech Pharma Plc?
Le Propriété du management de Midatech Pharma Plc est 11.91%
Quelle est la définition de Propriété du management?
La propriété d'un initié est calculée en divisant le nombre total d'actions possédées par des initiés (actionnaires détenant plus de 5% de la société ou un dirigeant ou un administrateur de la société) par le nombre total d'actions en circulation.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Propriété du management des entreprises dans Health Care secteur sur LSE par rapport à Midatech Pharma Plc
Que fait Midatech Pharma Plc?
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Entreprises avec propriété du management similaire à Midatech Pharma Plc
- Timberland a Propriété du management de 11.89%
- Precigen Inc a Propriété du management de 11.89%
- Idox Plc a Propriété du management de 11.90%
- Hanhua Co a Propriété du management de 11.90%
- Mexican Gold Mining a Propriété du management de 11.90%
- Smith Micro Software a Propriété du management de 11.91%
- Midatech Pharma Plc a Propriété du management de 11.91%
- Maitri Health Technologies a Propriété du management de 11.91%
- Radius Gold a Propriété du management de 11.93%
- Lazydays Inc a Propriété du management de 11.93%
- Salt Lake Potash a Propriété du management de 11.93%
- Golden Lake Exploration Inc a Propriété du management de 11.94%
- Studio City International a Propriété du management de 11.96%